Ph.D. Theses at the Leuven Lung Cancer Group
|
|
Vansteenkiste Johan (Catholic University Leuven, 1996): Staging and treatment of non-small cell lung cancer with ipsilateral mediastinal lymph node metastases: A clinical and literature study.
|
|
Read more...
|
|
|
|
Nackaerts Kris (Catholic University Leuven, 1998): Heparan sulfate proteoglycans in malignant cells.
|
|
Read more...
|
|
|
|
Lievens Yolande (Catholic University Leuven, 2002): Cost and economic evaluation of radiotherapy. Activity-based costing and modelling techniques.
|
|
Read more...
|
|
|
|
Sigrid Stroobants (Catholic University Leuven, 2002): Role of positron emission tomography with F-18-fluorodeoxyglucose in the diagnosis, staging and chemotherapy evaluation in patients with non-small cell lung cancer.
|
|
Read more...
|
|
|
|
Dooms Cristophe (Catholic University Leuven, 2008): Relationship of FDG-PET and biological aggressiveness in operable non-small cell lung cancer (NSCLC): what is the impact on prognosis and the influence of induction chemotherapy in stage IIIA-N2 NSCLC?
|
|
Read more...
|
|
|
Research Awards of the Leuven Lung Cancer Group
|
|
Mallinckrodt Award, 1996 (Dr. S. Stroobants, Dr P. Dupont) Mediastinal staging with FDG-PET in patients with potentially operable non-small cell lung cancer.
|
|
|
|
Upjohn Award, 1997 (Dr. S. Stroobants) Mediastinal staging with FDG-PET in patients with potentially operable non-small cell lung cancer.
|
|
|
|
CIS Jean Debiesse European Nuclear Medicine Award, 1998 (Dr. J. Vansteenkiste, Dr S. Stroobants) Contribution of FDG-PET scan to an improved management of diagnosis and treatment of non-small cell lung cancer.
|
|
|
|
ASCO Press Award for Innovative Clinical Research, 1999 (Dr. J. Vansteenkiste) Prognostic value of FDG-PET in non-small cell lung cancer.
|
|
|
|
G. Derscheid Award, 1999 (Dr. S. Stroobants) Contribution of FDG-PET scan to an improved management of locally advanced non-small cell lung cancer.
|
|
|
|
Eli-Lilly L. Hertel Chair in Respiratory Oncology, 2001 (Dr. J. Vansteenkiste) 3-yearly renewable externally funded chair at the Catholic University Leuven devoted to the further development of clinical research in lung cancer.
|
|
|
|
Amgen Chair in Supportive Cancer Care, 2003 (Dr. J. Vansteenkiste) 3-yearly renewable external fund at the Catholic University Leuven devoted to the further development of supportive care research in cancer.
|
|
|
|
Varian Award, 2003 (Prof. Y. Lievens) Cost and Economic Evaluation of Radiotherapy Activity-Based Costing and Modeling Techniques.
|
